Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of Age

Completed · Phase 1

Conditions studied: Infection

In brief

The purpose of this study is to determine the pharmacokinetics of ceftaroline in pediatric subjects

Key facts

Study ID

NCT00633126

Run by

Forest Laboratories

People needed

9

Starts

2008-03-01

Expected to finish

2009-02-01

Last updated by the study team

2017-03-14

Who can join

Age: 12 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Hospitalized and receiving antibiotic therapy for treatment of a suspected infection of any type
• Body mass index (weight [kg]/height squared [m2]) of no more than 30
• Males and females between 12 and 17 years of age, inclusive

You may not qualify if…

• History of any hypersensitivity or allergic reaction to any β-lactam antimicrobial
• Past or current history of epilepsy or seizure disorder
• Critically ill or unstable patients

Where it is running

• Investigational Site — Louisville, Kentucky, United States
• Investigational Site — Durham, North Carolina, United States
• Investigational site — Akron, Ohio, United States
• Invetigational Site — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.